Vegzelma 100 mg/4 ml

Vegzelma 100 mg/4 ml is a medicine authorised by Swissmedic under authorisation number 69166. The authorisation holder is IQONE HEALTHCARE SWITZERLAND SA. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 15 February 2023 and the authorisation is limited until 14 February 2028. ATC code L01FG01 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 69166
  • ATC L01FG01
  • Biotechnological medicines
Authorisation data
Authorisation number69166
NameVegzelma 100 mg/4 ml
Full nameVegzelma 100 mg/4 ml, solution à diluer pour perfusion
Authorisation holderIQONE HEALTHCARE SWITZERLAND SA
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01FG01
First authorisation15 February 2023
Authorisation validity14 February 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Vegzelma 100 mg/4 ml, solution à diluer pour perfusionA15 February 2023
2Vegzelma 400 mg/16 ml, solution à diluer pour perfusionA15 February 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01FG0107.16.1.A
21Durchstechflasche(n)L01FG0107.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Vegzelma 100 mg/4 ml authorised in Switzerland?

Yes. Vegzelma 100 mg/4 ml is authorised by Swissmedic under authorisation number 69166, data as of 01 September 2026. The authorisation is limited until 14 February 2028.

Which dispensing category does Vegzelma 100 mg/4 ml have?

Vegzelma 100 mg/4 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Vegzelma 100 mg/4 ml?

The authorisation holder is IQONE HEALTHCARE SWITZERLAND SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com